3 ASX healthcare shares with overseas income exposure

Below are 3 ASX healthcare shares offering global income exposure from the comfort of investing on the ASX.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Buying shares on the ASX doesn't necessarily mean the business operates solely within Australian borders – after all, the world is a big place and Australia is only a relatively small market. So to accelerate growth, many companies look across the water to other major markets such as the US, Europe and Asia.

Expanding overseas is not only about growth, however. A company that earns income in multiple countries also achieves a level of diversification, giving it some protection from any negative economic shocks from a single country or region.

For these 2 reasons, I think companies that can expand into overseas markets offer investors a great opportunity, giving the company greater room to grow while also providing some income diversification.

With that in mind, below are 3 ASX healthcare shares that are listed here in Australia, yet receive income globally.

Ramsay Health Care Limited (ASX: RHC)

Ramsay is Australia's largest private hospital operator with a market cap of around $13 billion. However outside of Australia Ramsay also has a large presence throughout continental Europe and the United Kingdom, with a small Asian segment also. Together, this gives it a total of 480 locations with a diverse mix of facilities across 11 countries.

In fact, making a rough calculation by converting the latest earnings figures for each region into the same base currency shows us that Ramsay earned around 57% of its revenue outside of Australia for the 6 months to 31 December 2019, with Europe contributing the lions share with around 49% of total revenue.

Medical Developments International Ltd (ASX: MVP)

Medical Developments is the company behind the 'green whistle', less commonly known as the drug Penthrox. Penthrox sales have grown both here in Australia and overseas thanks to the product's fast acting, self-administered and non-addictive pain relief.

In H1FY20, the company reported that Penthrox sales in Australia grew by 18%, however growth in Europe and the UK far surpassed this, growing at 42% in the UK and 35% throughout Europe during the period.

Medical Developments also plans to expand further throughout Europe, with its eyes on countries such as Germany, Hungary, Spain, and Greece. The company hopes to continue its growth in the region, which has seen its number of customers increase by around 250% over the last 2 years.

Medical Developments is also currently pursuing larger markets such as the US, China and Russia, however some clinical programs are currently either delayed or on provisional hold due to local health authorities shifting their focus toward COVID-19.

Nanosonics Ltd. (ASX: NAN)

Nanosonics develops a medical device called Trophon, which is used in hospitals to sterilise ultrasound probes. The device is automated, quick and doesn't require any chemicals.

Currently, Nonosonics' largest market is the US, by far, with almost 90% of its Trophon base being installed in North America. However, it has also been growing this base throughout Asia Pacific, Europe and the Middle East. Nanosonics' strongest base growth over the prior 12 months has come from Europe and the Middle East, albeit from a much lower starting point.

Continuing its global expansion, Nanosonics also recently had its first units installed in Japan, with regulatory and distribution strategies currently also being explored for China.

Foolish takeaway

I like looking for companies on the ASX which offer investors exposure to overseas markets. If a company is successful in more than one market there's a good chance it can be in many more, which opens the gates to a much, much larger addressable market. However, it's also important to ensure that a company's original business remains intact and steadily growing while it is pursuing markets abroad.

I believe each of the 3 ASX healthcare companies above will continue expanding into new markets outside of Australia. Additionally, each of their initial markets are still growing, giving me the confidence to believe in a bright future for each of them.

Michael Tonon owns shares of Medical Developments International Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia has recommended Medical Developments International Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Share Market News

Broker gives its verdict on BHP shares

Let's see what Bell Potter is saying about the Big Australian.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Woman holding gold bar and cheering.
Gold

Why Macquarie expects this surging ASX 200 gold stock could leap another 40%

Macquarie forecasts another year of strong outperformance from this fast-rising ASX 200 gold miner.

Read more »

A young woman looks at here phone as she strides out in an airport dragging her wheelie bag behind her and smiling widely.
Broker Notes

Macquarie tips 15% upside for this ASX 200 industrials stock

Is this transportation business preparing for take-off?

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »